Literature DB >> 27461940

Divergence of helper, cytotoxic, and regulatory T cells in the decidua from miscarriage.

Yasuhiko Ebina1, Shigeki Shimada2, Masashi Deguchi1, Yoko Maesawa1, Norifumi Iijima3, Hideto Yamada1.   

Abstract

PROBLEM: The aim of this prospective study was to evaluate phenotypic differences of helper T (Th), cytotoxic T (Tc), and regulatory T (Treg) cells in the deciduae of missed miscarriage with a normal chromosome karyotype of a fetus (MN) and missed miscarriage with an abnormal chromosome karyotype of a fetus (MA). METHODS OF STUDY: The decidua of 19 MN and 28 MA was obtained. Additionally, the decidua of 15 induced abortion (IA) and the endometrium of 19 non-pregnant women (EM) were obtained. IFN-γ(+) , IL-17(+) , CD25(high) Foxp3(+) cells in CD4(+) (Th) cells, and IFN-γ(+) cells in CD8(+) (Tc) cells were evaluated by flow cytometry.
RESULTS: The percentages of IFN-γ(+) Tc and CD4(+) CD25(high) Foxp3(+) (Treg) cells in MN were significantly increased as compared with MA and IA. The percentage of IFN-γ(+) Th in MN was increased as compared with IA.
CONCLUSION: Activation of IFN-γ(+) Tc and Treg cells in the decidua might be associated with the pathophysiology underlying MN.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cytotoxic T cells; helper T cells; miscarriage; pregnancy; regulatory T cells

Mesh:

Year:  2016        PMID: 27461940     DOI: 10.1111/aji.12546

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

Review 1.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

2.  Correlation between unexplained recurrent spontaneous abortion with CD4+CD25+ regulatory T-cell and killer cell immunoglobulin-like receptor levels.

Authors:  Xiaozhen Quan; Xuezhou Yang
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

3.  Deep Surveying of the Transcriptional and Alternative Splicing Signatures for Decidual CD8+ T Cells at the First Trimester of Human Healthy Pregnancy.

Authors:  Weihong Zeng; Xinmei Liu; Zhicui Liu; Ying Zheng; Tiantian Yu; Shaliu Fu; Xiao Li; Jing Zhang; Siming Zhang; Xiaoling Ma; Xiao-Rui Liu; Xiaoli Qin; Asma Khanniche; Yan Zhang; Fuju Tian; Yi Lin
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

Review 4.  Preterm Birth in Women With HIV: The Role of the Placenta.

Authors:  Nadia M Ikumi; Mushi Matjila
Journal:  Front Glob Womens Health       Date:  2022-03-15

5.  Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.

Authors:  Caroline Nørgaard-Pedersen; Kaspar Nielsen; Rudi Steffensen; Line Eriksen; Malene Møller Jørgensen; Ulrik Schiøler Kesmodel; Ole Bjarne Christiansen
Journal:  BMJ Open       Date:  2022-09-22       Impact factor: 3.006

6.  VIP Promotes Recruitment of Tregs to the Uterine-Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment.

Authors:  Lucila Gallino; Vanesa Hauk; Laura Fernández; Elizabeth Soczewski; Soledad Gori; Esteban Grasso; Guillermina Calo; Nora Saraco; Esperanza Berensztein; James A Waschek; Claudia Pérez Leirós; Rosanna Ramhorst
Journal:  Front Immunol       Date:  2020-01-08       Impact factor: 7.561

7.  Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs.

Authors:  Judith Wienke; Laura Brouwers; Leone M van der Burg; Michal Mokry; Rianne C Scholman; Peter Gj Nikkels; Bas B van Rijn; Femke van Wijk
Journal:  JCI Insight       Date:  2020-09-17

Review 8.  T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.

Authors:  Wenjuan Wang; Nayoung Sung; Alice Gilman-Sachs; Joanne Kwak-Kim
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.